Financhill
Back

Intra-Cellular Therapies Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
38

ITCI
Intra-Cellular Therapies

Last Price:
66.97
Seasonality Move:
-6.93%
Buy
72

VRTX
Vertex Pharmaceuticals

Last Price:
441.98
Seasonality Move:
8.93%
Sell
38
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Vertex Pharmaceuticals (VRTX) is a Buy

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $445.87. The Score for VRTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • VRTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $65.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $445.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight buying pressure.

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.32 Sell
Relative Strength Index (14 RSI): 41.48 Sell
Chaikin Money Flow: 421582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.45 - 74.29) Sell
Bollinger Bands (100): (65.99 - 72.19) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.14 Buy
Relative Strength Index (14 RSI): 79.29 Buy
Chaikin Money Flow: 137998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (393.29 - 428.23) Buy
Bollinger Bands (100): (403.87 - 430.75) Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.78 Sell
20-day SMA: 69.19 Sell
50-day SMA: 68.67 Sell
200-day SMA: 62.8 Buy
8-day EMA: 66.34 Sell
20-day EMA: 68 Sell
50-day EMA: 68.71 Sell
200-day EMA: 64.66 Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 433.69 Buy
20-day SMA: 414.7 Buy
50-day SMA: 410.31 Buy
200-day SMA: 388.62 Buy
8-day EMA: 434.24 Buy
20-day EMA: 421.19 Buy
50-day EMA: 414 Buy
200-day EMA: 390.76 Buy

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $2.05 per share, and an increase next year of $1.12 per share.

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):